Mike Tyson reveals doctors gave him translucent blood injection that left him feeling weird during stem cel – The Sun

MIKE TYSON has revealed he was injected with nearly-translucent blood in his bid to make a comeback... and the former heavyweight champ said it made him feel "weird".

The 53-year-old - who retired from boxing in 2005 - has announced his intention to dust off the gloves and return to compete in exhibition bouts.

2

His return to action has been aided by stem-cell research therapy, that has left him feeling like a "different person".

He said: "You know what I had done? I had stem-cell research therapy.

"I feel like a different person but I can't comprehend why I feel this way. It's really wild what scientists can do."

Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition that usually takes the form of a bone marrow transplantation.

In a recent interview with rapper LL Cool J on the Rock the Bells Radio show on SiriusXM, Tyson opened up on the effects the treatment has had on him.

Commenting on the mental aspect of training for a fight for the first time in 15 years, he said: "My mind wouldnt belong to me.

"My mind would belong to somebody that disliked me enough to break my soul, and I would give them my mind for that period of time.

"Six weeks of this and Id be in the best shape Ive ever dreamed of being in. As a matter of fact, Im going through that process right now. And you know what else I did, I did stem-cell research."

Tyson was then asked whether that meant if his white blood had been spun and then put back in, to which he replied: "Yes. As they took the blood it was red and when it came back it was almost transfluid (sic).

"I could almost see through the blood, and then they injected it in me.

"And Ive been weird ever since, Ive got to get balanced now."

2

FIGHT FOR THE AGESHow heavyweights Tyson and Briggs compare with combined age of 101

THE REAL DEALHolyfield warns Tyson he won't settle for any nonsense in exhibition fight

EVERY LIDDELL HELPSTyson urged to return at 53 as he 'still has it', says UFC icon Liddell

MIKE DROPTyson return 'not something' Hearn wants to promote but 'intrigued' by comeback

LOW BLOWHolyfield snubs Mike Tyson as hardest hitter and instead picks George Foreman

MIKE DROPMike Tyson recalls prison visit from Tupac and hitting a fellow inmate

WHAT IS STEM CELL TREATMENT USED FOR?

Stem cell transplants are carried out when bone marrow is damaged or isnt able to produce healthy blood cells.

It can also be used to replace damaged blood cells as the result of intensive cancer treatment.

Here are conditions that stem cell transplants can be used to treat:

Iron Mike has been called out by former rival Evander Holyfield to complete their trilogy following their two meetings in 1990s.

And his unusual methods for getting back in shape seem to be working.

Tyson is looking in incredible condition as he uploaded a clip of himself that showed off his ferocious power and speed.

Read more here:
Mike Tyson reveals doctors gave him translucent blood injection that left him feeling weird during stem cel - The Sun

Who Believe? Chad Coulter’s spirit lives on through his son on and off the field – Dave Campbell’s Texas Football

Chad Coulter embodied everything good about Orangefield, Texas. His work ethic, his selfless motivation, his love for his family and neighbor. He passed away from cancer in 2019, but his spirit lives on in his son, Coby Coulter.

If you have a chance to look up toward the heavens today, give it a second and you might hear the faint whispers of a man yelling Who Believe? as he did so often around Orangefield, Texas.

Go ahead and shout back We Believe if youre able. It would mean a lot to the Coulters.

Chad Coulter is no longer with us; he succumbed to his battle with Non-Hodgkin Lymphoma shortly after the 2019 football season. But his memory most definitely lives on in the tight-knit community 25 minutes east of Beaumont.

Coulter bled orange and white. He grew up a Bobcat and proudly wore the No. 72 as he became an all-state offensive lineman before going off to play at Kilgore College.

He was known around town as the man that would yell the first part of Orangefields school motto, Who Believe?

Someone that most definitely does is his son Coby, a junior-to-be who wears the same number and plays the same position in honor of his pops.

He was a nice guy who cared for everyone in Orangefield, Coby said. He really loved the people around here. He loved being around people. He loved all of us, the whole family.

Chad did a bit of everything in the Orangefield school system. He coached track, was the junior high boys athletic coordinator, was an offensive line coach at the high school, taught science.

Hell, at one point he was the assistant softball coach, said Josh Smalley, Orangefields head football coach.

He didnt stop coaching football until he had a couple of heart attacks.

When he got done with stem cell therapy the doctor told him he needed to take two to three months off. But he loved going to work, said his wife, Heggie Coulter. He loved being with those kids. He was in everything.

Added Smalley: He never complained. Im sure there were days when he would go and get chemo in the morning and then come to practice after school, and Im sure he didnt feel like doing it but did it because he loves the kids. Never heard the guy complain. He was a happy-go-lucky guy.

He battled cancer for over three years until it reached his brain. The doctors told his family they could try to treat it, but werent sure if it would do any good. He got more treatments, but by September, it had returned strong enough to paralyze half of his face.

Then in October it paralyzed the other half of his face, Heggie said. We knew in November that he didnt have much time left.

Despite all of this, Chad was there to watch his son at every Orangefield game except the Bobcats bi-district playoff loss to Franklin.

He would always show with his actions, Coby said. Hed always lend a helping hand to anyone in need. He was always there to help.

As you could imagine, the perseverance that Coby showed through all of this was as inspirational as any motivational speech Smalley could have ever conjured up for his team.

To be a sophomore in high school and deal with the death of his father, I cant imagine what he had to go through daily, Smalley said. To have your dad battle cancer and you still have to be a kid and go to school, go to football practice and play in a game, he is a special young man.

The impact that Chad had on the community was nowhere more apparent than at his funeral. Over 500 people showed up. Athletes stood for the entire 2-hour service with their finger in the air. Coaches, trainers, co-workers, high school and college teammates shared memories instead of the traditional eulogy.

What Chad Coulter means to this school district and this community you cant put into words, Smalley said. Everybody that has taught, coached here or played here reached out and loved the family.

His word for the school year was Live.

This meant more to him than staying alive, Heggie said. He wanted to inspire others to live each day to the fullest no matter what obstacles they faced.

Thats a message that Coby lives by every day.

It made me want to be a better person and to always put others before yourself, he said.

After Chads passing, students started a petition to name the stadium after Coach Coulter. It had about 2,000 signatures before COVID-19 put things on pause.

He was the epitome of what it means to be a Bobcat; toughness, hard-worker, no fear, Smalley said. He definitely put that into his kids and family.

Boy, did he.

He would always tell me that I couldnt guard him, laughed Coby, who could squat 425 as an incoming freshman and can now squat 600 pounds. I would have taken him easy.

Who believe?

See the rest here:
Who Believe? Chad Coulter's spirit lives on through his son on and off the field - Dave Campbell's Texas Football

Doctor, Heal Thyself: Physician Burnout In The Wake Of Covid-19 – Forbes

Physician burnout and suicide were epidemics before the current pandemic.

Nationwide, our doctors are jumping from rooftops, overdosing in call rooms and hanging themselves in hospital chapels. Its medicines dirty secret.

This unnerving account by Pamela Wible, MD during her 2015 TEDMED talk sent chills down my spine. Dr. Wible described the death of one physician by bullying, hazing and sleep deprivation a torture technique adding that each year, more than one million Americans lose their doctor due to suicide. Her cell phone has become an unofficial suicide hotline. The founder of Ideal Medical Care, Dr. Wible is also featured in the groundbreaking documentary, Do No Harm, which has been virtually screened every Sunday in May at 8pm EST. Suicide is an occupational hazard of our profession.

Physician burnout was an epidemic BEFORE the Covid-19 pandemic. According to a 2018 study, 400 physicians die by suicide each year double that of the general population. In addition, doctors have the highest suicide rate of any profession in the U.S including combat veterans. From an economic standpoint, studies estimate that physician burnout is costing the health care system approximately $4.6 billion per year. So, how do we stop this dreadful reality? Read on (HINT: its NOT through resilience and wellness trainings).

Many doctors view medicine as a calling, entering the field with immense altruism paired with a passion for science and healing the sick. The erosion of these intrinsic motivators leads to burnout which psychologist Christina Maslach defines as a syndrome of emotional and physical exhaustion, depersonalization and diminished personal accomplishment.

The stress of long hours, no sleep, poor eating, inadequate protection, the fear of contaminating loved ones, the fear of dying and seeing patients die no matter what you do, the disrespect by hospital administrators and the fear of being fired, all remain the reality for those who are in the thick of things, denounced Lynette Charity, MD, an anesthesiologist who speaks nationwide about physician burnout.

Studies also show that burnout is associated with negative clinical outcomes: decreased quality of patient care; increased number of medical errors; and higher rates of addiction, depression and suicide among physicians.

Dr. Lynette Charity, an anesthesiologist and physician advocate, speaks nationwide about burnout ... [+] among doctors.

Burnout has nothing to do with weakness, laziness or incompetence. The prevailing attitude, report Pamela Hartzband, MD and Jerome Groopman, MD in a recent NEJM article, was that burnout is a physician problem and those who cant adapt need to get with the program or leave. Turns out that structural and systemic issues are heavy culprits. Despite lip service to patient-centered care, many physicians believe the current healthcare system is propelled by money and metrics, according to Hartzband and Groopman. Doctors are well-meaning and willing to work long hours, and hospital executives know this and exploit it, as Danielle Ofri, MD aptly asserts in The Business of Health Care Depends on Exploiting Doctors and Nurses.

Medical workers in protective clothing move the body of a deceased patient to a refrigerated ... [+] overflow morgue outside the Wyckoff Heights Medical Center in the Brooklyn borough of New York City, the epicenter of the Covid-19 pandemic.

The medical field is at a crisis. This pandemic has exposed many cracks in the U.S. healthcare system. From inadequate testing and personal protective equipment (PPE) to overcrowded emergency departments, frontline health staff are putting their lives at risk to care for highly infectious patients debilitated by Covid-19. And yet medical professionals are responding to this crisis with unprecedented selflessness, resilience and compassion.

For many physicians, Covid-19 may be the proverbial straw that breaks the camels back as they isolate themselves physically from their family and friends while encountering a surge of sickness and death, said Nisha Mehta, MD, radiologist, physician advocate and keynote speaker.

Here are a few real-world examples. About a month into the pandemic, at the end of a difficult shift, an infectious disease physician with 20 years of experience, texted me the following: Just admitted a 28yo pregnant woman in 2nd trimester w COVID. About to get intubated. I hate these days. Two weeks later, this same physician texted: I just started sobbing. I mean, bawling. But in the bathroom so my 6yo wouldnt see.

A doctor checks on a Covid-19-infected patient connected to a ventilator.

Some hospitals have created the position, Chief Wellness Officer. Others have offered resilience and meditation workshops, social hours and tips for maximizing productivity. But, according to Hartzman and Groopman, none of these solutions address the underlying problem: a profound lack of alignment between caregivers values and the reconfigured health care system. Here are some strategies that may actually curtail the wave of physician burnout and suicide:

1. Reduce administrative burden This includes prior authorizations, disability paperwork and the electronic medical record (EMR) which has simply become a burdensome billing tool. Let the bean counters and the C-Suite collect the data and enter it into the EMRs, suggested Dr. Charity, adding: Provide scribes for the doctors.

2. Flexibility over schedules A 2017 study showed that physician input in scheduling was one of the few systems solutions that reduced burnout as it allowed for individual practice styles and patient interactions.

3. Mental health support Because burnout can lead to depression, anxiety, PTSD and secondary trauma, appropriate and timely mental health treatment is critical and can include counseling and medications. In NY state, text NYFRONTLINE to 741741 to access 24/7 emotional support services.

Access to timely mental health support is critical in reducing burnout.

4. Reduce gender bias The National Academy of Medicine reported that burnout may be 20-60% higher among female vs male physicians. Over 70% of women doctors experienced gender discrimination; they are consistently paid less than their male counterparts, less likely to be referred by their professional titles and less likely to be promoted. Female physicians also spend 8.5 additional hours per week on childcare and other domestic duties, while men reported spending an extra 40 minutes on domestic work.

6. Diversify Doctor Voices We need more women and women of color to be in decision-making positions. Minority voices are not being heard, and they are being disproportionately harmed.

7. Speak Out - If youre a physician whos going through a hard time, I promise you youre not alone. Please talk to somebody. And if you see a colleague suffering, please get her/him help. You may just be saving a life. Call National Suicide Prevention Lifeline 1-800-273-TALK (8255).

In addition to the above recommendations, a group of New York doctors (myself included) created a petition to advocate for physician protection and compensation which is being sent to legislators. It can be signed by non-healthcare workers.

Dr. Nisha Mehta, a physician advocate: "So many physicians contact me with fears, frustrations and ... [+] sadness as they experience unprecedented challenges emotionally, physically and financially."

*****

Medicine is a calling for many. But is it really worth dying for? I dont think so. Doctors are people, too. And thats not being trite. In order to stem the tide of physician burnout and suicide, we all have a role to play. If we want our doctors to be whole and full of joy, we must reaffirm their humanity and their value in society. Medical culture and health care systems must change but this will only happen when theyre forced to change. Physicians must first acknowledge and heal their own pain and suffering - for their sake and that of their patients and communities.

Read more:
Doctor, Heal Thyself: Physician Burnout In The Wake Of Covid-19 - Forbes

Outbreak on edge of Navajo Nation overwhelms rural hospital – Yahoo Lifestyle

GALLUP, N.M. (AP) On the eve of New Mexico's shutdown of bars and restaurants to stem the spread of the coronavirus, the city of Gallup came alive for one last night of revelry.

Before the night was out in the desert oasis on the fringes of the Navajo Nation, 98 people were detained for public intoxication and sent to sober up at a detox center. Several homeless people also sought refuge in the same cinder block building, which doubles as a shelter. Somewhere in the mix, lurked the virus.

The outbreak seeded at the NaNizhoozhi Center would combine with the small, local hospitals ill-fated staffing decisions and its well-intentioned but potentially overambitious treatment plans to create a perfect storm that has overwhelmed doctors and nurses and paralyzed this community in the states hard-hit northwest.

In all, 22 people infected with the coronavirus were transferred from the detox center to Rehoboth McKinley Christian Hospital, the only acute care medical center for the general public within 110 miles (180 kilometers) of Gallup.

They were putting multiple cots in one room to accommodate them, said pulmonologist Rajiv Patel, who helped lead the hospitals initial response.

To care for that influx, any available doctor was pressed into service, including those who normally don't handle critically ill patients, Patel said.

Thats right when we overloaded, said hospital CEO David Conejo. Now weve got too many patients, and too few (staff) to help.

Rehoboths eight intensive care beds are full, and now it has to transfer all coronavirus patients with severe breathing problems away from the facility and the adjacent Gallup Indian Medical Center, which attends exclusively to the Native American community.

Of about 500 medical and support staff, at least 32 hospital workers have become infected, and doctors and nurses say that they all live with the fear of spreading the virus to their colleagues and relatives.

Conejo blames Patel for the fact that the hospital became overwhelmed, saying the doctor took on more COVID-19 patients than the staff could handle because of his ambition but also good intentions.

Story continues

But Patel who arrived at Rehoboth in March from an Army reserve stint in Kuwait said the hospital simply didn't have enough staff with the experience to provide the right care and struggled to train more quickly. Patel has since left to work at Flagstaff Medical Center in Arizona.

Twice, the doctor said, alarms went off during the night on breathing machines only to be misinterpreted by overnight staff. Within two days of those missteps, he and colleagues decided that severely ill coronavirus patients would have to go elsewhere a heart-wrenching decision that meant sick people would be treated far from family and one that underscored the consequences of not having adequate care in the region.

It was an easy decision because it was the right thing to do for patients, said Patel, whose wife is Navajo. It was very saddening for me personally because my heart and soul are completely invested in the health situation on the reservation."

Many nurses and doctors, meanwhile, say staffing at the hospital was inadequate because of Conejo's move to cut back on nurses in the first week of March to offset declining hospital revenues after elective surgeries were suspended. They voiced their discontent at a recent protest calling for his resignation.

We knew it was coming to McKinley County, there wasnt any ifs, ands or buts. I was directed that I had to let go of 17 agency nurses, said Felicia Adams, chief nursing officer who has recovered from COVID-19. We want to take care of our patients, we dont want to have to send them away.

Conejo defended his oversight, noting that he deferred to the hospitals board of trustees and a team of nurses and physicians on final decisions. He also said the hospital couldnt afford not to cut staff in March and that the facility wanted to reduce overall employment to qualify for small-business assistance. But Adams and others believe Conejo put profits ahead of care.

Physician Caleb Lauber said that, as experienced contract nurses were let go in March, unfamiliar responsibilities were thrust upon other nurses given only on-the-fly training.

New Mexicos state auditor is seeking more information about the county-owned hospital's finances from its private operators. State health officials and philanthropists, meanwhile, are recruiting more than a dozen volunteer medical professionals and have hired a new critical care physician for the hospital.

While much of New Mexico is showing signs of emerging from the initial wave of the pandemic, stubbornly high rates of infection and death persist in the states northwest corner including in the Navajo Nation that extends into Arizona and Utah. More than half of New Mexicos roughly 6,100 confirmed infections are in Native Americans.

For most people, the coronavirus causes mild or moderate symptoms. For some, especially older adults and people with existing health problems, it can cause more severe illness and lead to death.

As the Navajo have suffered in this pandemic, so, too has Gallup, whose fate has long been tied to the neighboring Navajo Nation. In normal times, the citys population of 22,000 can quickly quadruple in size since it is a crucial source of supplies and water for faraway Navajo households, many of which lack full plumbing.

The city is also a destination for many of the most marginalized Navajo, those who have left home and ended up on Gallup's streets, often as they grapple with alcohol addiction. Officials suspect that the coronavirus whipped through the homeless population, and some passed through the NaNizhoozhi Center, putting the liquor-tax funded shelter and detox center at the heart of the city's outbreak.

The city and its rural outskirts account for about 30% of COVID-19 infections statewide, with 78 related deaths as of Monday.

To stem the spread, Gallup was subject to an extreme 10-day lockdown this month cutting the city off from many of those who depend on it for supplies. Authorities have now set up free water stations and deliveries to avoid the risk of transmission posed by coin-operated water stations, where hand after hand scooped out returned change.

Now, the NaNizhoozhi Center is also part of the response as it steers destitute people infected by the coronavirus toward isolation in rooms at four otherwise unoccupied motel buildings. Some 140 people are currently participating in the impromptu system, and officials hope it will interrupt a treadmill of infections among Gallups homeless population.

But the virus has also taken its toll on the center. In addition to the 22 residents who became infected, several staff have been sickened by the virus and some simply stopped showing up, said Kevin Foley, executive director of the center. Six jobs now are open at a rate of $10 and hour, with just one application, he said.

He yearns for a Hollywood ending.

I wish that all those people would come over in those space suits and just clean the place for good," he said, "but its not like that.

___

Associated Press writer Felicia Fonseca contributed to this report from Flagstaff, Arizona.

See original here:
Outbreak on edge of Navajo Nation overwhelms rural hospital - Yahoo Lifestyle

More than 290000 Covid-19 cases in Mena – MEED

COUNTRYLATEST UPDATES

Saudi Arabia

Covid-19 pandemic latest:

Actions to slow the spread of Covid-19:

Measures to minimise the economic crisis:

Covid-19 pandemic latest:

Actions to slow the spread of Covid-19:

Measures to minimise the economic crisis:

Covid-19 pandemic latest:

Actions to slow the spread of Covid-19:

Measures to minimise the economic crisis:

Covid-19 pandemic latest:

Actions to slow the spread of Covid-19:

Measures to minimise the economic crisis:

Covid-19 pandemic latest:

Actions to slow the spread of Covid-19:

Measures to minimise the economic crisis:

Covid-19 pandemic latest:

Actions to slow the spread of Covid-19:

Measures to minimise the economic crisis:

Covid-19 pandemic latest:

Actions to slow the spread of Covid-19:

Measures to minimise the economic crisis:

Covid-19 pandemic latest:

Actions to slow the spread of Covid-19:

Measures to minimise the economic crisis:

Covid-19 pandemic latest:

Actions to slow the spread of Covid-19:

Measures to minimise the economic crisis:

Covid-19 pandemic latest:

Actions to slow the spread of Covid-19:

Measures to minimise the economic crisis:

Covid-19 pandemic latest:

Actions to slow the spread of Covid-19:

Measures to minimise the economic crisis:

Covid-19 pandemic latest:

Actions to slow the spread of Covid-19:

Measures to minimise the economic crisis:

Covid-19 pandemic latest:

Actions to slow the spread of Covid-19:

Measures to minimise the economic crisis:

Covid-19 pandemic latest:

Actions to slow the spread of Covid-19:

Measures to minimise the economic crisis:

Covid-19 pandemic latest:

Actions to slow the spread of Covid-19:

Measures to minimise the economic crisis:

Covid-19 pandemic latest:

Actions to slow the spread of Covid-19:

Measures to minimise the economic crisis:

Covid-19 pandemic latest:

Actions to slow the spread of Covid-19:

Financial measures to minimise the economic crisis:

Link:
More than 290000 Covid-19 cases in Mena - MEED

Beware This COVID-19 Vaccine ‘Study’ From an 80s Teen Tech Titan and a Carnivorous Plant Smuggler – The Daily Beast

A 1980s teen tech tycoon has teamed up with a one-time international carnivorous plant smuggler and a veterinarian to promote what they claim is a possible vaccine for COVID-19but experts warn the budding research project could contribute to the flood of misinformation plaguing the coronavirus crisis.

The trio co-authored a study suggesting existing inoculations for measles, mumps, and rubella could help protect against the ravages of COVID-19. Their report, published through an obscure environmental charity called the World Organization, is also seeking coronavirus survivors to volunteer for blood work to test their theory.

They also want Dr. Anthony Fauci, the nations foremost infectious diseases specialist, or another team of epidemiologists to take on their research.

Jeff Gold, the computer scientist and chief investigator behind the report, told The Daily Beast that news reports of low fatality rates among those under 50 inspired him to search for a cause. Then he stumbled across the creation date of the combined vaccine for measles, mumps, and rubella: 1971.

The only thing that could be physically different about people in the younger demographic, people under 50 versus people over 50, was a vaccine, Gold argued.

But Dr. Jim Conway, a pediatric infectious disease specialist at the University of Wisconsin-Madison, said readers need to be cautious when people are trying to draw associations that dont have a lot of biological plausibility.

While data mining is fine, theres much more risk of uncovering associations that have no true correlation versus finding things that actually have causation, Conway said.

World Organization, not to be confused with the World Health Organization, has published the reporttitled MMR Vaccine Appears to Confer Strong Protection from COVID-19: Few Deaths from SARS-CoV-2 in Highly Vaccinated Populationson its website and promoted it in press releases and in local news and social media. The group based their findings off of published epidemiological data on COVID-19 death rates and MMR vaccination campaigns.

Right now, it is a national priority to develop a safe and effective vaccine for the COVID-19 virus, and the race is on to do this, with dozens of companies and millions of dollars spent in this effort, the report states. As part of this effort, there should be an immediate investigation of using the already available MMR vaccine in controlled studies to show a protective benefit.

Gold collected mortality data first from South Korea and Hong Kong, which have large-scale modern immunization programs and also low mortality ratesbut which also implemented early and aggressive testing regimens and mask-wearing policies after the COVID-19 outbreak. He then examined locations such as Madagascar and Pacific Island nations which reported few or no deaths and also have wide-scale MMR inoculation programs. He contrasted these findings with Belgium, which the study says didnt even offer MMR vaccinations until 1985, and it wasnt until 1995 that it began giving the recommended two doses of MMR vaccinations per person.

The findings were so compelling to the 53-year-old Gold, he said, that he ran to his local Walgreens to get the MMR vaccine himself.

You can make data say anything you want if you pick and choose the right stuff.

Scientists have floated existing vaccinationsparticularly the nearly century-old Bacillus Calmette-Guerin live, attenuated tuberculosis vaccine and the 60-year-old oral polio vaccineas a possible defense against coronavirus. Both vaccines have been shown to boost innate immunity against other viral infections.

The MMR vaccine also contains live weakened forms of measles, mumps and rubella.

Experts, however, warn not to draw quick conclusions from Golds hypothesis.

Everybody is trying to pitch in, and I dont blame these people for trying to do something helpful, Conway told The Daily Beast. But just because two things are happening doesnt mean one has to do with the other, he added.

For example, as a vaccination advocate who battles misinformation about vaccines and autism, Conway says he shows people a slide that indicates the disorder rises perfectly with an increase in the sale of organic foods. You can make data say anything you want if you pick and choose the right stuff, he said.

One factor missing from the study is pre-existing comorbidities. Its also lacking information on how many tests each country conducted, Conway said.

Weve been using MMR vaccines for decades and they have done nothing to prevent SARS and other coronaviruses, he added. Theres not a lot of reason biologically that other vaccines would protect against COVID.

Dr. Ajay K. Sethi, an infectious disease epidemiologist and associate professor of population health sciences at the University of Wisconsin-Madison, cautioned that there is no evidence Gold and his co-investigators used a scientific approach to test their hypothesis that different exposure to vaccines between younger and older people may account for this different morbidity rate [in COVID-19].

According to Sethi, some red flags in the report include that the study design is not provided and the authors do not cite relevant research that led to their hypothesis. Theres also no statistical tests to determine if the findings are due to chance.

Other explanations for the relationship between older age and COVID deaths are not explored even though much has been written about this subject, Sethi continued. The countries chosen and presentation of information appear to be cherry-picked to support their conclusion. Evidence of objectivity is lacking. Citations are not provided for many of the claims made.

He said conclusions should not be drawn until three questions are addressed: Are the findings instead due to statistical chance? Can bias explain the findings? And could the reason for the finding be explained by some other variable?

Meanwhile, Gold is pushing for wider recognition of his MMR vaccine theory. Its Golds first apparent foray into immunology; for most of the past decade, he and the World Organization have run a pet adoption networkRescue Me!and the Georgia Nature Center, an attraction in Watkinsville geared toward school children. But he spent the 1980s making startling discoveries of another kind.

U.S. News & World Report profiled Gold in 1983, when he was the then-16-year-old founder of Double-Gold Software, having developed an early anti-piracy program called Lock-It Up and an algorithm that could solve a Rubiks Cube. When the magazine paid Gold a visit, the teenage genius was angry hed need a cosigner for the furniture hed ordered for his suite of offices. Back then, he told the outlet he didnt believe in failure.

If you start a company and go bankrupt, it doesnt mean you have failed. You will have learned from the experience, said the Silicon Valley wunderkind, who had dropped out of high school to pursue his tech businesses.

According to a 1984 Washington Post feature on young computer capitalists, Gold was raking in more than $100,000 a year and driving a Datsun sports car with vanity plates: DBL GOLD. In his memoir The Accidental Millionaire, entrepreneur Gary Fong recalled meeting Gold at the University of California, Santa Barbara, around the same time, and described him as a generational genius.

By the early 1990s, Gold had cultivated an interest in carnivorous plantsone he shared with a friend, William Baumgartl, a doctor at the Allegiant Spine Institute in Nevada who is now involved in Golds MMR vaccine push.

Baumgartl, an anesthesiologist and stem cell specialist, said his friends findings impressed him when Gold shared them earlier this year. The data suggests a correlation between those who get the MMR and have protection, Baumgartl told The Daily Beast. It may be the basis of a very inexpensive, and very easy to initiate, vaccine therapy for this disease.

The files of the Nevada State Board of Medical Examiners indicate that Baumgartls history as a physician is unblemished. But his personal record is not so pristine: In 1995, he and two friends pleaded guilty to smuggling hundreds of carnivorous Nepenthes pitcher plants into the U.S. from Indonesia and Malaysia, in violation of the Endangered Species Act. Just a few years earlier, Gold had faced a similar accusation from the Venezuelan government, which alleged he had stolen carnivorous orchids from the slopes of the South American nations Tepui mesas. Gold disputed the accusationsand still doesbut subsequently dissolved a nonprofit he had founded to study the insect-swallowing flora.

Theres a need now to have someone, an epidemiologist, take this to the next level.

Baumgartl, for his part, blamed his imbroglio on bad legal advice from one of his accomplices, an Oakland deputy district attorney. I accounted for what I did, accepted responsibility, and it was a very minor charge, the doctor said, adding that he served no hard time for the crime.

Meanwhile, the ragtag team of researchers has linked a University of Cambridge study on MMR vaccines to their own, calling it a corroborating report.

In April, U.K. scientists uploaded a study to the server medRxiv which identified some chemical similarities between COVID-19 and the measles, mumps, and rubella viruses, and a correlation between rubella antibodies and a lower impact by the novel coronavirus. The report, which is not peer-reviewed, concludes that vaccination of at risk age groups with an MMR vaccination merits further consideration as a time-appropriate and safe intervention.

I suddenly felt like this is such an important connection that's been made, and they've made, most importantly, that really knocks this out of the park, Gold said of finding the Cambridge paper. They came up with the same thing we did coming at it with completely different angles.

Still, Rocio Hernandez, one of the researchers on the Cambridge study, objected to the World Organizations interpretation of their research in a statement to the Daily Beast. He pointed to disclaimers on medRxiv which warn that papers there should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information. He further underscored that the Cambridge teams work is still in its embryonic stages, and requires considerable further lab research.

In short, no, they are not using the work appropriately, it cannot be used to corroborate their own conclusions for obvious reasons, Hernandez told the Daily Beast. It is preliminary work, based on preliminary lab tests, and the hypothesis still requires further lab/clinical work to confirm or refute it. Our study leads are currently seeking funds for this.

Undeterred, Gold has been aggressively pushing his paper, sending it to Dr. Fauci, and to the National Institute of Health. And this week, on the advice of several friends, he began his campaign to get it noticed in the press.

They tell me you need to get this to the media before the people in the NIH are going to pay attention to it, Gold said. "What we're saying is if this is true, and what Cambridge more importantly has come across, if this is true, then there is a solution to this pandemic that could be put into action within weeks.

In an email, the NIHs National Institute of Allergy and Infectious Diseases confirmed that the World Organization reached out to its staff but that it is currently not studying a connection between the MMR vaccine and COVID-19.

Another associate of Golds, New Mexico-based veterinarian Dr. Larry Tilleythe author and editor of multiple volumes on animal ailmentstold The Daily Beast that he researched medical literature as part of the study, which was Golds brainchild. But he stressed theyre seeking government researchers or experienced epidemiologists to adopt the hypothesis. Theres a need now to have someone, an epidemiologist, take this to the next level, said Tilley, who also got a booster shot because of Golds findings. What we found is all preliminary.

We just simply saw something that didnt make sensewhy certain countries were having such a high death rate, Tilley added. I say it to people now: Im not an expert. But it seems like theres something there.

Tilley said the World Organization is trying to reach anyone who can run with their findings, whether its people in D.C., Dr. Faucis group, NIH, or CDC.

Readers of the study have already flocked to the groups Facebook page, asking if they should get a measles booster shot and if doctors administer them on request. One woman commented, I should be okay then. MMR is one of the vaccines I got in 2010, it was required for my citizenship process.

Another commenter said she was born in 1973 and asked if shed likely had the MMR vaccine. World.Org replied, You probably did, but at that time they only gave one rather than two in a row, which was less effective. Id recommend getting a series of two again now. Whether or not our study ends up proving this 100%, we already have a lot of evidence pointing that way, it cant hurt to get them again.

Hubby and I are going to CVS tomorrow, the woman replied. Thanks for the info!!!

Before The Daily Beast reached out, the World Organization had begun soliciting COVID-19 survivors through its website to participate in a new study in which volunteers would travel to the nearest Quest Diagnostics lab and get tested for MMR antibodies.

Sethi, the infectious disease epidemiologist, expressed concern that the studys authors are using their paper as the basis for recruiting COVID-19 survivors to participate in human subjects research.

In a time of crisis, fear and uncertainty can cause individuals to not exercise better judgment when evaluating the legitimacy of information found online, Sethi told The Daily Beast. COVID survivors may be eager to participate in research to get answers about the illness they had experienced and to contribute to the effort to address the pandemic.

Sethi, who also researches the spread of public health conspiracies, said that based on the studys appearance, a reader may mistake the paper as being scientifically rigorous.

Moreover, the name of the organization that carried out the study is called World Organization. Someone could easily confuse that with World Health Organization and be misled into thinking that the WHO carried out the study, Sethi added.

Indeed, at least one outlet, TechStartups.com, has confused Golds group with the World Health Organization and misattributed its research accordingly.

When encountering seemingly scientific papers, consumers should check to see if they were published in peer-reviewed journals, Sethi said. Those journals should have a reputation for publishing high-quality research in the field of study. Authors may instead choose to publish their research papers on preprint servers, like medRxiv, arXiv, and bioRxiv, which are well known by members of the scientific community, Sethi said.

Posting articles to these preprint servers is the norm in many fields, and by doing so, the research is immediately accessible to anyone and is inherently subject to continuous peer review once it is posted. By publishing their paper on their own website instead of a well known preprint servers, the authors have bypassed the peer-review process, Sethi added.

World Organizations report came with a caveat at the end: In the interest of providing early information to other researchers and the public, many COVID-19 researchers including ourselves are publishing early release articles like this one which are not considered final. The information contained herein, and certainty of any conclusions being reached, are subject to change as this study continues.

Sethi said, The disclaimer in the article is a good thing, but it's not a substitute for posting the research on a credible website where it can undergo peer-review.

But Gold defended himself and his work, claiming he hoped only to encourage further inquiry into a potential life-saving answer to the current crisis.

Were not trying to pretend to be the epidemiologists here, he said. If this is not a solution, I think it's equally important for someone to go through this data and analyze it.

Shortly after talking with The Daily Beast, Gold reconfigured the World Organizations website to redirect to ResearchGate, an academic networking and preprint site, where his study had gone up one day prior.

Conway, the pediatric infectious diseases expert, said that until such studies are peer-reviewed, theyre as good as social media.

Were in a historic era in one way, because science is so much more transparent than it used to be because of the internet, Conway said. This includes posting studies on websites before theyve been tested widely by other scientists.

And rushing to conclusions can have dangerous consequences. Conway noted how New York doctors prescribed the anti-malaria drug hydroxychloroquine in light of observational studies, which had not been peer-reviewed clinical trials. Then came a Food and Drug Administration warning that tests had indicated the medicine could cause potentially life-threatening heart rhythm problems, even though it hadnt proven safe or effective for treating COVID-19.

One glimmer of information and hope suddenly leads to a snowballing effect, Conway told The Daily Beast. Since we dont have anything clear, people want to act. They would prefer to not just stand there but do something.

Originally posted here:
Beware This COVID-19 Vaccine 'Study' From an 80s Teen Tech Titan and a Carnivorous Plant Smuggler - The Daily Beast

New Stem Cell-Based Topical Solution Helps Bald People Regrow Hair – SciTechDaily

A clinical trial showed the ability of a stem cell-based topical solution to regrow hair in people with male/female pattern baldness.

The results of a clinical trial released today (May 18, 2020) in STEM CELLS Translational Medicinedemonstrate how a topical solution made up of stem cells leads to the regrowth of hair for people with a common type of baldness.

Androgenetic alopecia (AGA) commonly known as male-pattern baldness (female-pattern baldness in women) is a condition caused by genetic, hormonal and environmental factors. It affects an estimated 50 percent of all men and almost as many women older than 50. While it is not a life-threatening condition, AGA can lower a persons self-esteem and psychological well-being. There are a few FDA-approved medications to treat hair loss, but the most effective can have side effects such as loss of libido and erectile dysfunction. Therefore, the search continues for a safer, effective treatment.

Adipose tissue-derived stem cells (ADSCs) secrete several growth hormones that help cells develop and proliferate. According to laboratory and experimental studies, growth factors such as hepatocyte growth factor (HGF), vascular endothelial growth factor (VEGF), insulin-like growth factor (IGF) and platelet-derived growth factor (PDGF) increase the size of the hair follicle during hair development.

A more enriched adipose-derived stem cells-constituent extract (ADSC-CE) with stem cell proteins is obtained by disruption of the ADSC membrane using a low frequency of ultrasound wave. Credit: AlphaMed Press

Recent studies have shown that ADSCs promote hair growth in both men and women with alopecia. However, no randomized, placebo-controlled trial in humans has explored the effects and safety of adipose-derived stem cell constituent extract (ADSC-CE) in AGA. We aimed to assess the efficacy and tolerability of ADSC-CE in middle-aged patients with AGA in our study, hypothesizing that it is an effective and safe treatment agent, said Sang Yeoup Lee, M.D., Ph.D., of the Family Medicine Clinic and Research Institute of Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital in South Korea. He led the group of researchers, which also included colleagues from Pusan National University School of Medicine, Pusan National University Yangsan Hospital and T-Stem Co., Ltd.

The team recruited 38 patients (29 men and nine women) with AGA and assigned half to an intervention group that received the ADSC-CE topical solution and half as a control group that received a placebo. Twice daily, each patient applied the ADSC-CE topical solution or placebo to their scalp using their fingers.

At the end of 16 weeks, the group that received the ADSC-CEs had a significant increase in both hair count and follicle diameter, reported the studys senior author, Young Jin Tak, M.D., Ph.D.

Dr. Lee added, Our findings suggest that the application of the ADSC-CE topical solution has enormous potential as an alternative therapeutic strategy for hair regrowth in patients with AGA, by increasing both hair density and thickness while maintaining adequate treatment safety. The next step should be to conduct similar studies with large and diverse populations in order to confirm the beneficial effects of ADSC-CE on hair growth and elucidate the mechanisms responsible for the action of ADSC-CE in humans.

For the millions of people who suffer from male-pattern baldness, this small clinical trial offers hope of a future treatment for hair regrowth, said Anthony Atala, M.D., Editor-in-Chief ofSTEM CELLS Translational Medicineand director of the Wake Forest Institute for Regenerative Medicine. The topical solution created from proteins secreted by stem cells found in fat tissue proves to be both safe and effective. We look forward to further findings that support this work.

###

Reference: A Randomized, Double-blind, Vehicle-Controlled Clinical Study of Hair Regeneration Using Adipose-Derived Stem Cell Constituent Extract in Androgenetic Alopecia by Young Jin Tak, Sang Yeoup Lee, A Ra Cho and Young Sil Kim, 18 May 2020, STEM CELLS Translational Medicine.DOI: 10.1002/sctm.19-0410

AboutSTEM CELLS Translational Medicine:STEM CELLS Translational Medicine(SCTM), co-published by AlphaMed Press and Wiley, is a monthly peer-reviewed publication dedicated to significantly advancing the clinical utilization of stem cell molecular and cellular biology. By bridging stem cell research and clinical trials, SCTM will help move applications of these critical investigations closer to accepted best practices. SCTM is the official journal partner of Regenerative Medicine Foundation.

About AlphaMed Press: Established in 1983, AlphaMed Press with offices in Durham, NC, San Francisco, CA, and Belfast, Northern Ireland, publishes two other internationally renowned peer-reviewed journals:STEM CELLS, celebrating its 38th year, is the worlds first journal devoted to this fast paced field of research.The Oncologist, also a monthly peer-reviewed publication, entering its 25th year, is devoted to community and hospital-based oncologists and physicians entrusted with cancer patient care. All three journals are premier periodicals with globally recognized editorial boards dedicated to advancing knowledge and education in their focused disciplines.

Link:
New Stem Cell-Based Topical Solution Helps Bald People Regrow Hair - SciTechDaily

Clinical Trial Shows Topical Stem Cell Treatment Leads to Hair Regrowth in Common Type of Baldness – Technology Networks

The results of a new clinical trial published in the journal STEM CELLS Translational Medicine demonstrate how a topical solution made up of stem cells leads to the regrowth of hair for people with a common type of baldness.1

Unfortunately, there are only a few FDA-approved medications to treat hair loss, and these carry a myriad of associated side effects including a negative impact on sexual functioning. There is therefore a pertinent need to develop anti-hair loss treatments that lack such side effects.

Emerging research has demonstrated the potential application of stem cells, particularly adipose tissue-derived stem cells (ADSCs), in this space. ADSCs are a type of mesenchymal stem cell that secrete several growth hormones that facilitate cell development and proliferation.

As previous research has demonstrated that growth factors such as hepatocyte growth factor, vascular endothelial growth factor, insulin-like growth factor and platelet-derived growth factor increase the size of hair follicles during hair development, scientists have explored whether ADSCs can promote hair growth in men and women with alopecia.2,3 The results of such research have been positive, however, a randomized, placebo-controlled trial of such a therapeutic approach in AGA did not exist until now.

"Recent studies have shown that ADSCs promote hair growth in both men and women with alopecia. However, no randomized, placebo-controlled trial in humans has explored the effects and safety of adipose-derived stem cell constituent extract (ADSC-CE) in AGA," says Sang Yeoup Lee, M.D., Ph.D., of the Family Medicine Clinic and Research Institute of Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital. "We aimed to assess the efficacy and tolerability of ADSC-CE in middle-aged patients with AGA in our study, hypothesizing that it is an effective and safe treatment agent."

Participants were instructed to apply 2mL of solution to the area in which they experienced hair loss, twice every day for a total of 16 weeks, massaging the solution into their scalp using their fingers. Each subjected visited the research center four times in total throughout the study, and were requested to keep a diary to record when they were using the solution.

To measure whether the solution was significantly impacting hair growth, the scientists measured changes in total hair number and hair thickness as confirmed by close contract photographs using a standardized technique. This was the primary efficacy variable. Photographs were taken at baseline, eight weeks and 16 weeks after using the product. At baseline, participants received a dot tattoo over their scalp to ensure that the photographs were taken at the same spot at each follow up. The secondary efficacy variables of the study included analysis of global photographs of the participants' scalps by an investigator, and self-evaluation of hair growth by the participants.

Whilst these results are promising, the authors note several limitations to the study. When assessing the secondary efficacy outcomes, the researchers found that the improvement score provided by the investigator was higher in the intervention group than the control, but this was not a significant increase. Additionally, the evaluation provided by the subject was lower in the intervention group. The scientists suggest that a contributing factor here could be the study duration, positing the idea that the length of time in which the participants were involved in the trial may not have been sufficient for them to notice a visual improvement. Furthermore, the self-report assessment could have been limited in validity as subjects may have been impacted by their own expectations towards the intervention. A solution to consider going forward could be to ask participants about their expectations regarding the magnitude of improvement at baseline.

Lee adds, "Our findings suggest that the application of the ADSC-CE topical solution has enormous potential as an alternative therapeutic strategy for hair regrowth in patients with AGA, by increasing both hair density and thickness while maintaining adequate treatment safety. The next step should be to conduct similar studies with large and diverse populations in order to confirm the beneficial effects of ADSC-CE on hair growth and elucidate the mechanisms responsible for the action of ADSC-CE in humans."

"For the millions of people who suffer from male-pattern baldness, this small clinical trial offers hope of a future treatment for hair regrowth," says Anthony Atala, M.D., Editor-in-Chief ofSTEM CELLS Translational Medicineand director of the Wake Forest Institute for Regenerative Medicine. "The topical solution created from proteins secreted by stem cells found in fat tissue proves to be both safe and effective. We look forward to further findings that support this work."

References:

1. Tak, Lee, Cho and Kim. (2020). A randomized, doubleblind, vehiclecontrolled clinical study of hair regeneration using adiposederived stem cell constituent extract in androgenetic alopecia. Stem Cells Translational Medicine. DOI: https://doi.org/10.1002/sctm.19-0410.

2. Ramdasi S, Tiwari SK. (2016). Growth factors and cytokines secreted in conditioned media by mesenchymal stem cells-promising possible therapeutic approach for hair regeneration. J Stem Cells. https://www.ncbi.nlm.nih.gov/pubmed/28296872.

3. Lee et al. (2001). Hepatocyte growth factor (HGF) activator expressed in hair follicles is involved in in vitro HGF-dependent hair follicle elongation. J Dermatol Sci. 25:156-163.

See the original post here:
Clinical Trial Shows Topical Stem Cell Treatment Leads to Hair Regrowth in Common Type of Baldness - Technology Networks

Unproven stem cell products are being peddled as COVID-19 ‘therapies,’ U of M researcher reports – MinnPost

Coronavirus health scams are rampant, with businesses taking advantage of peoples fears to sell all sorts of unproven products for the prevention and treatment of COVID-19. Some of these snake oil cures are innocuous, such as elderberry juice, but others can be harmful, such as colloidal silver.

Among the products with considerable potential for harm are unproven stem cell therapies. Unfortunately, the emergence of this particular line of sham COVID-19 treatments isnt all that surprising. For more than a decade, businesses have been aggressively pitching unsubstantiated and unlicensed stem cell products to vulnerable and often desperate individuals with illnesses or injuries for which no known treatment exists, such as Alzheimers disease, amyotrophic lateral sclerosis (ALS), chronic obstructive pulmonary disease (COPD) and spinal cord injuries. The results have sometimes been deadly.

There are some medical conditions for which stem cell therapies have been shown to be safe and effective, but they are few in number mostly cancer and several blood and immune disorders.

Leigh Turner, a bioethicist at the University of Minnesota, has been investigating the direct-to-consumer marketing of spurious stem cell therapies and related exosome products in the United States for nearly a decade. In an article published recently in the journal Cell Stem Cell, Leigh describes the latest twist in this cynical saga: how some stem cell businesses are seizing the [COVID-19] pandemic as an opportunity to profit from hope and desperation.

MinnPost spoke with Turner late last week about what he found when researching that paper. The following is an edited transcript of the interview.

MinnPost: Companies seem to be using the same kind of marketing strategies to sell unproven stem cell therapies for COVID-19 as they have for other medical conditions.

Leigh Turner: Yes. These are opportunistic businesses. They look for marketplace opportunities, ways to generate e-revenue streams. And the COVID-19 pandemic is another business opportunity. Its not like theyve pivoted away from what they did in the past. If they were marketing stem cell treatments for Parkinsons disease, or ALS or spinal injuries, they havent stopped doing that. Theyve just added that theyve now got a stem cell treatment or an exosome therapy to treat or prevent COVID-19.

MP: They seem to be marketing their products primary as immune system boosters.

Leigh Turner

MP: At least one company is telling people that they should bank their stem cells to use as a treament if they get infected with the coronavirus.

LT: There are several business models at play right now. One is, come on in and get your stem cell immune booster to reduce your chances of getting COVID-19. They may also claim it will reduce your symptoms should you get it. Another marketing pitch is a bit more cautious. It says that if you come in now when youre in good health, they will bank your cells. Youll pay for the initial extraction of cells and also monthly or yearly for banking. The company then claims that should you fall ill with COVID-19 down the road, youll have those healthy cells available for you to use. Of course, they dont offer a lot of detail about how the cells would actually help you. You just supposed to take it for granted that they will.

MP: Theres no evidence of that.

LT: No. Its all just pseudoscience. But there is a meaningful hypothesis behind it. Thats how these businesses operate by fusing science with pseudoscience, credible research with junk claims.

MP: What is that hypothesis?

LT: There are companies and academic institutions right now that are interested in testing stem cell products, but not as immune boosters, not to prevent COVID-19 and not to eliminate the virus if someone gets infected. The studies right now are focusing on a very particular population of people with COVID-19 those who are typically in ICUs, suffering from acute respiratory distress syndrome. The hypothesis is that if certain types of stem cell products are administered to those people, we may be able to reduce inflammation in the lungs and help shorten the illness. But its a hypothesis.

MP: A good one?

LT: Its not an outrageous hypothesis. If you look at the existing literature, there have been studies done in the past that used stem cells for lung and respiratory disease. So far, those studies suggest that if you use clinical-grade stem cells and if you do it in a very rigorous way the safety profile is pretty good. But none of those studies has established extensive evidence of efficacy yet. Ideally, what you want is carefully designed, carefully conducted clinical trials testing that hypothesis and generating that evidence. These businesses the ones marketing stem cell therapies directly to individuals are not part of that scientific world.

MP: How do those businesses pull their customers in? How do they find them?

LT: They are typically big on social media. Im talking generally here, but they have Twitter accounts. They have YouTube channels. They have a Facebook page. Theyre not just putting up a website and hoping that somebody walks in the door. They hire social media marketing companies. They use marketing firms. They have pretty sophisticated marketing strategies that are tailored to particular demographics. It may be that they are targeting an elderly population, for example, because if youre interested in reaching people with COPD, youre not going to be trying to find 18-year-olds. Some businesses here in Minneapolis and elsewhere will have what they describe as educational seminars, which are basically infomercials. They are marketing events. They will try to get people to come to a convention center, a hotel [conference] room or a restaurant. Everything is free, but what theyll do is use hard-sell sales tactics to get people to commit, to write a check. Often theyll tell people that if they sign on today, theyll knock $2,000 or so off the price. But, of course, theyre not holding these events right now. They cant have these public gatherings.

MP: So, how are they selling people these products now, during the pandemic?

LT: More of it is happening online. One company, for example, uses a graduated pricing model. If its one person, its one price point. If its you and a family member, you both get a break on the procedure. And if its you and two additional family members, the price goes down even more. They use these things to try to get people to come in the door. One company in California has adapted to the pandemic in a different way. They have a do-it-yourself model. You dont have to even come into the clinic. You can buy their kit, and they ship it to your home. You then do the procedure at your dining room table.

MP: These stem cell products and treatments are quite expensive.

LT: Yes, some of the businesses Ive look at charge tens of thousands of dollars, although thats not necessarily for treating COVID-19. For COVID-19, it appears to be in the thousands-of-dollars category. In some cases, we dont know. The businesses can be pretty cagey. In some cases, they try to size up the customer and figure out how much they can extract from that person.

MP: Government agencies are cracking down on some of these stem cell businesses.

LT: The FDA (Food and Drug Administration), FTC (Federal Trade Commission) and Department of Justice have said that theyre going to be aggressive with dealing with these scams. And they have. Some businesses have already received letters from the regulators. That may be having a deterrent effect during the pandemic. Some businesses may want to jump in, but are afraid to do so. They may be waiting to see what happens before they take the chance.

MP: But the regulatory agencies are obviously not finding all of the businesses marketing unproven COVID-19 therapies.

LT: There is a lot of marketing fraud. And sometimes its quite challenging to figure out whats going on. Some of the clinics that I looked at didnt say, Were offering an immune booster for COVID-19. It was more just chatter. Clinics would put up a seven-minute video from one of their doctors about COVID-19 and emerging stem-cell research coming out of China, saying it was really encouraging. Then they would say, If you have any questions about stem cells and COVID-19, give us a call. So, whats the takeaway when a business does that? Does that mean they are selling stem cell treatments for COVID-19? Or are they just trying to get people to call? Its hard to know whats happening. If I had to guess, I say its a workaround. The businesses dont want to put it on their website, because thats too easy for someone from the FTC or the FDA to find. If they just put up a video, they can say theyre not marketing anything, that it was just meant to be educational.

MP: These businesses seem to rely on anecdotal cases or really small studies from China to support their claims.

LT: They use China in a couple of different ways. There was a case report, for example, that was published as a preprint. It wasnt published by a journal. It hasnt gone through peer review. It was just a preprint that someone put online. Its the case of a single individual with COVID-19 who received stem cells. Thats been written up in a very hyperbolic way, when really, its just a case report. Its one person. Some people get COVID-19 and recover anyway. You cant draw any conclusions from it about stem cells being efficacious, but its been written up that way. There was another study, very preliminary research, in which mesenchymal stem cells were administered to seven individuals with COVID-19 with various degrees of severity. A placebo was given to three individuals. The article doesnt provide the source of the stem cells. Nor does it provide much insight about the individuals who were given placebos, although they appear to be about 10 years older than [those receiving the stem cells]. It raises some interesting questions. It provides a basis for further research. But, unfortunately, some of the news media reports have been hyperbolic. Stem cell businesses use both these papers when marketing directly to consumers. They refer to these studies, and they also attach themselves to the bubbly media coverage.

MP: Consumers need to know that these products can be dangerous.

LT: Yes. The danger comes in several forms. Part of it is that these are financial scams lifting money off people who are worried and anxious. But, also, giving someone a product that hasnt been carefully tested in well-designed clinical trials raises a lot of concerns. Some businesses have released contaminated stem cell products into the marketplace. People end up getting infections and having to be hospitalized. It can be a very serious thing. Theres also the possibility that the wrong type of cell goes to the wrong part of the body and causes harm. When a company claims, for example, that a stem cell product will regenerate lung tissue and be an immune booster, one thing I would worry about is pulmonary embolisms. If someone is being given something that hasnt been thoroughly tested, its hard to know what would go wrong, but its easy to know something could go wrong.

FMI: Youll find the article on Cell Stem Cells website.

The rest is here:
Unproven stem cell products are being peddled as COVID-19 'therapies,' U of M researcher reports - MinnPost

Global Stem Cell Partnering Deals Collection (2010-2020): Access to Headline, Upfront, Milestone and Royalty Data – PRNewswire

DUBLIN, May 18, 2020 /PRNewswire/ -- The "Global Stem Cell Partnering Terms and Agreements 2010-2020" report has been added to ResearchAndMarkets.com's offering.

This report provides comprehensive understanding and unprecedented access to the stem cell partnering deals and agreements entered into by the worlds leading healthcare companies.

The report provides a detailed understanding and analysis of how and why companies enter Stem Cell partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and proceed to commercialization of outcomes.

This report provides details of the latest Stem Cell agreements announced in the life sciences since 2010.

The report takes the reader through a comprehensive review Stem Cell deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Stem Cell partnering deals.

The report presents financial deal term values for Stem Cell deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.

The middle section of the report explores the leading dealmakers in the Stem Cell partnering field; both the leading deal values and most active Stem Cell dealmaker companies are reported allowing the reader to see who is succeeding in this dynamic dealmaking market.

One of the key highlights of the report is that over 600 online deal records of actual Stem Cell deals, as disclosed by the deal parties, are included towards the end of the report in a directory format - by company A-Z, stage of development, deal type, therapy focus, and technology type - that is easy to reference. Each deal record in the report links via Weblink to an online version of the deal.

In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners. Whilst many companies will be seeking details of the payment clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases and databases do not.

The initial chapters of this report provide an orientation of Stem Cell dealmaking.

A comprehensive series of appendices is provided organized by Stem Cell partnering company A-Z, stage of development, deal type, and therapy focus. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in Stem Cell partnering and dealmaking since 2010.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Stem Cell technologies and products.

Analyzing actual contract agreements allows assessment of the following:

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/9pqrta

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets Laura Wood, Senior Manager [emailprotected]

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904 Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

http://www.researchandmarkets.com

Here is the original post:
Global Stem Cell Partnering Deals Collection (2010-2020): Access to Headline, Upfront, Milestone and Royalty Data - PRNewswire